• Members of the previous forum can retrieve their temporary password here, (login and check your PM).

Singing the praises of mate de coca

Migrated topic.

dreamer042

musuq jaguarqa filoyuq
Staff member
Admin
Donator
Kuka Mama or Mama Kuka (in quechua: Mother coca) was a goddess of health and joy. She was originally a promiscuous woman who was cut in half by her many lovers. Her body grew into the first coca plant, the leaves of which men were only allowed to chew (to bring health and happiness) after having given a woman an orgasm.

Erythroxylum coca
Erythroxylum_coca.jpg


The poor misunderstood little coca plant, she really is beautiful.

Since ancient times the Inca have considered this plant sacred and incorporated it into their religious ceremonies and daily lives. Used as a tea; it is a safe, effective, all-natural stimulant that is a healthy and nutritious way to improve attention and increase energy. It tastes wonderful, combines very well with many other types of herbs, and doesn't give the jitteriness or crash that is so common with caffeine.

Coca tea is readily (and it seems legally) available on amazon.com

Yum!
 
Fascinating, thank you for sharing the origin tale for Mama Coca. Just the other day, I heard that the origin of Mama Iboga involved violence against women as well. Perhaps it's that so many of these plant teachers seem to have a feminine essence, and so shamans thought a woman gave her life to give them souls?
 
dreamer042 said:
Coca tea is readily (and it seems legally) available on amazon.com

Not sure about it mate. It`s defo NOT LEGAL in UK
The Misuse of Drugs Regulations 2001 said:
SCHEDULE 1
Regulation 3


CONTROLLED DRUGS SUBJECT TO THE REQUIREMENTS OF REGULATIONS 14, 15, 16, 18, 19, 20, 23, 26 AND 27


1. The following substances and products, namely -

(a) Bufotenine

Cannabinol

Cannabinol derivatives not being dronabinol or its stereoisomers

Cannabis and cannabis resin

Cathinone

Coca leaf

Concentrate of poppy-straw

Eticyclidine

Etryptamine

Lysergamide

Lysergide and other N-alkyl derivatives of lysergamide

Mescaline

Methcathinone

Psilocin

Raw opium

Rolicyclidine

Tenocyclidine

4-Bromo-2,5-dimethoxy-a-methylphenethylamine

N,N-Diethyltryptamine

N,N-Dimethyltryptamine

2,5-Dimethoxy-alpha,4-dimethylphenethylamine

N-Hydroxy-tenamphetamine

4-Methyl-aminorex

(b) any compound (not being a compound for the time being specified in sub-paragraph (a) above) structurally derived from tryptamine or from a ring-hydroxy tryptamine by substitution at the nitrogen atom of the sidechain with one or more alkyl substituents but no other substituent;

(c) the following phenethylamine derivatives, namely -

Allyl(alpha-methyl-3,4-methylenedioxyphenethyl)amine

2-Amino-1-(2,5-dimethoxy-4-methylphenyl)ethanol

2-Amino-1-(3,4-dimethoxyphenyl)ethanol

Benzyl(alpha-methyl-3,4-methylenedioxyphenethyl)amine

4-Bromo-ß,2,5-trimethoxyphenethylamine

N-(4-sec-Butylthio-2,5-dimethoxyphenethyl)hydroxylamine

Cyclopropylmethyl(alpha-methyl-3,4-methylenedioxyphenethyl)amine

2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)ethylamine

2-(4,7-Dimethoxy-2,3-dihydro-1H-indan-5-yl)-1-methylethylamine

2-(2,5-Dimethoxy-4-methylphenyl)cyclopropylamine

2-(1,4-Dimethoxy-2-naphthyl)ethylamine

2-(1,4-Dimethoxy-2-naphthyl)-1-methylethylamine

N-(2,5-Dimethoxy-4-propylthiophenethyl)hydroxylamine

2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)ethylamine

2-(1,4-Dimethoxy-5,6,7,8-tetrahydro-2-naphthyl)-1-methylethylamine

alpha, alpha-Dimethyl-3,4-methylenedioxyphenethylamine

alpha, alpha-Dimethyl-3,4-methylenedioxyphenethyl(methyl)amine

Dimethyl(alpha-methyl-3,4-methylenedioxyphenethyl)amine

N-(4-Ethylthio-2,5-dimethoxyphenethyl)hydroxylamine

4-Iodo-2,5-dimethoxy-a-methylphenethyl(dimethyl)amine

2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)ethylamine

2-(1,4-Methano-5,8-dimethoxy-1,2,3,4-tetrahydro-6-naphthyl)-1-methylethylamine

2-(5-Methoxy-2,2-dimethyl-2,3-dihydrobenzofuran-6-yl)-1-methylethylamine

2-Methoxyethyl(alpha-methyl-3,4-methylenedioxyphenethyl)amine

2-(5-Methoxy-2-methyl-2,3-dihydrobenzofuran-6-yl)-1-methylethylamine

ß-Methoxy-3,4-methylenedioxyphenethylamine

1-(3,4-Methylenedioxybenzyl)butyl(ethyl)amine

1-(3,4-Methylenedioxybenzyl)butyl(methyl)amine

2-(alpha-Methyl-3,4-methylenedioxyphenethylamino)ethanol

alpha-Methyl-3,4-methylenedioxyphenethyl(prop-2-ynyl)amine

N-Methyl-N-(alpha-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

O-Methyl-N-(alpha-methyl-3,4-methylenedioxyphenethyl)hydroxylamine

alpha-Methyl-4-(methylthio)phenethylamine

ß,3,4,5-Tetramethoxyphenethylamine

ß,2,5-Trimethoxy-4-methylphenethylamine

(d) any compound (not being methoxyphenamine or a compound for the time being specified in sub-paragraph (a) above) structurally derived from phenethylamine, an N-alkylphenethylamine, alpha-methylphenethylamine, an N-alkyl-alpha-methylphenethylamine, alpha-ethylphenethylamine, or an N-alkyl-alpha-ethylphenethylamine by substitution in the ring to any extent with alkyl, alkoxy, alkylenedioxy or halide substitutents, whether or not further substituted in the ring by one or more other univalent substituents;

(e) any compound (not being a compound for the time being specified in Schedule 2) structurally derived from fentanyl by modification in any of the following ways, that is to say -

(i) by replacement of the phenyl portion of the phenethyl group by any heteromonocycle whether or not further substituted in the heterocycle;

(ii) by substitution in the phenethyl group with alkyl, alkenyl, alkoxy, hydroxy, halogeno, haloalkyl, amino or nitro groups;

(iii) by substitution in the piperidine ring with alkyl or alkenyl groups;

(iv) by substitution in the aniline ring with alkyl, alkoxy, alkylenedioxy, halogeno or haloalkyl groups;

(v) by substitution at the 4-position of the piperidine ring with any alkoxycarbonyl or alkoxyalkyl or acyloxy group;

(vi) by replacement of the N-propionyl group by another acyl group;

(f) any compound (not being a compound for the time being specified in Schedule 2) structurally derived from pethidine by modification in any of the following ways, that is to say -

(i) by replacement of the l-methyl group by an acyl, alkyl whether or not unsaturated, benzyl or phenethyl group, whether or not further substituted;

(ii) by substitution in the piperidine ring with alkyl or alkenyl groups or with a propano bridge, whether or not further substituted;

(iii) by substitution in the 4-phenyl ring with alkyl, alkoxy, aryloxy, halogeno or haloalkyl groups;

(iv) by replacement of the 4-ethoxycarbonyl by any other alkoxycarbonyl or any alkoxyalkyl or acyloxy group;

(v) by formation of an N-oxide or of a quaternary base.

2. Any stereoisomeric form of a substance specified in paragraph 1.

3. Any ester or ether of a substance specified in paragraph 1 or 2.

4. Any salt of a substance specified in any of paragraphs 1 to 3.

5. Any preparation or other product containing a substance or product specified in any of paragraphs 1 to 4, not being a preparation specified in Schedule 5.
 
Back
Top Bottom